Skip to content

Clinical trials

Genetic Diseases, Inborn trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Genetic Diseases, Inborn Country / region: Netherlands Clear all

47 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20062
20093
20101
20112
20131
20143
20151
20163
20171
20182
20196
20215
20225
20231
20241
20251
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Recruiting11
Terminated5
Unknown status5
Active, not recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ModernaTX, Inc.5
Pharming Technologies B.V.4
Maastricht University Medical Center3
Novo Nordisk A/S3
Vertex Pharmaceuticals Incorporated3
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company2
Erasmus Medical Center2
Novartis Pharmaceuticals2
REGENXBIO Inc.2
AIRNA Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Genetic Diseases, Inborn47
Metabolic Diseases9
Metabolism, Inborn Errors8
Infant, Newborn, Diseases5
Cardiovascular Diseases4
Congenital Abnormalities4
Lung Diseases4
Muscular Diseases4
Muscular Disorders, Atrophic4
Muscular Dystrophies4

Trials

Showing 51 to 47 of 47. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.